{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:33:05Z","timestamp":1786735985195,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pathol Microbiol"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/ijpm.ijpm_861_19","type":"journal-article","created":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T07:13:31Z","timestamp":1587107611000},"page":"194","source":"Crossref","is-referenced-by-count":11,"title":["Dual-color dual-hapten in situ hybridization (D-DISH) \u2013 Comparison with fluorescence in situ hybridization (FISH) for HER2\/neu testing in breast cancer"],"prefix":"10.4103","volume":"63","author":[{"given":"TanujaM","family":"Shet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PoojaK","family":"Gajaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Tambe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trupti","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asawari","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SangeetaB","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0377-4929.282719-1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer: Correlation of relapse and survival with amplification of the HER-2\/neu oncogene","author":"Slamon","year":"1987","journal-title":"Science"},{"key":"key-10.4103\/0377-4929.282719-2","first-page":"852748","article-title":"Human epidermal growth factor receptor 2 (HER2) in cancers: Overexpression and therapeutic implications","author":"Iqbal","year":"2014","journal-title":"Mol Biol Int"},{"key":"key-10.4103\/0377-4929.282719-3","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ctrv.2013.09.001","article-title":"HER2 testing: Current status and future directions","author":"Perez","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"key-10.4103\/0377-4929.282719-4","first-page":"1","article-title":"Robust and accurate digital measurement for HER2 amplification in HER2 equivocal breast cancer diagnosis","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"key-10.4103\/0377-4929.282719-5","first-page":"526","article-title":"Improved detection of HER2 by a quasi-targeted proteomics approach using aptamer\u2013peptide probe and liquid chromatography\u2013Tandem mass spectrometry","author":"Zhou","year":"2017","journal-title":"Clin Chem"},{"key":"key-10.4103\/0377-4929.282719-6","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/jnci\/djs317","article-title":"Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: A retrospective cohort study","author":"Bowles","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"key-10.4103\/0377-4929.282719-7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/abt\/tby003","article-title":"Trastuzumab-mediated cardiotoxicity: Current understanding, challenges, and frontiers","author":"Mohan","year":"2018","journal-title":"Antib Ther"},{"key":"key-10.4103\/0377-4929.282719-8","doi-asserted-by":"crossref","first-page":"144","DOI":"10.12809\/hkmj144458","article-title":"Comparison of fluorescence in-situ hybridisation with dual-colour in-situ hybridisation for assessment of HER2 gene amplification of breast cancer in Hong Kong","author":"Tang","year":"2016","journal-title":"Hong Kong Med J"},{"key":"key-10.4103\/0377-4929.282719-9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.prp.2013.01.006","article-title":"Comparison of dual-color dual-hapten brightfield in situ hybridization (DDISH) and fluorescence in situ hybridization in breast cancer HER2 assessment","author":"Kosa","year":"2013","journal-title":"Pathol Res Pract"},{"key":"key-10.4103\/0377-4929.282719-10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/PAI.0000000000000304","article-title":"Comparison of Dual-ISH (DISH) with Fluorescence in situ hybridization (FISH) and correlation with immunohistochemical findings for HER2\/Neu status in breast carcinoma","author":"Layfield","year":"2017","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"key-10.4103\/0377-4929.282719-11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1309\/AJCP6CXS8OSRHXIR","article-title":"Bright-field HER2 Dual in situ hybridization (DISH) assay vs Fluorescence in situ hybridization (FISH) \u2013 Focused study of immunohistochemical 2+cases","author":"Gao","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"key-10.4103\/0377-4929.282719-12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/ajcp\/aqw117","article-title":"Comparison of HER2 dual-color and fluorescence in situ hybridization in breast cancer","author":"Shao","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"key-10.4103\/0377-4929.282719-13","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1309\/AJCP13GJAOJAYJMW","article-title":"Comparison of Fluorescence in situ hybridization (FISH) and Dual-ISH (DISH) in the determination of HER2 status in breast cancer","author":"Mansfield","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"key-10.4103\/0377-4929.282719-14","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/PAS.0b013e3181d96231","article-title":"Silver in situ hybridization (SISH) for determination of HER2 gene status in breast carcinoma: Comparison with FISH and assessment of interobserver reproducibility","author":"Papouchado","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"key-10.4103\/0377-4929.282719-15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.31524\/bkkmedj.2015.09.001","article-title":"Reproducibility in the assessment of HER2 DISH in breast cancer","author":"Anekpuritanang","year":"2015","journal-title":"Bangkok Med J"},{"key":"key-10.4103\/0377-4929.282719-16","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s12282-015-0664-1","article-title":"Bright-field HER2 dual in situ hybridization (DISH) assay on breast cancer cell blocks: A comparative study with histological sections","author":"Nishimura","year":"2016","journal-title":"Breast Cancer"}],"container-title":["Indian Journal of Pathology and Microbiology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:35:47Z","timestamp":1786732547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJPM.IJPM_861_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"alternative-id":["282719"],"URL":"https:\/\/doi.org\/10.4103\/ijpm.ijpm_861_19","relation":{},"ISSN":["0377-4929"],"issn-type":[{"value":"0377-4929","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}